e-ISSN: 2717-7157
  • Home
  • Aims and Scope
  • Editorial Board
  • Instructions for Authors
  • Table of Contents
  • Contact
  • Türkçe
Current Issue
Archive
Search
Online Subscription Login
Subscription Form
Most Popular
Download Articles Read Articles
Automated Perimetry
Carbonic Anhydrase Inhibitors
Intra Ocular Lens Power Calculation and Optic Biometry...
Visual Field Defects in Glaucoma
Visual Field Defect and Retinal Nerve Fiber Layer Defect in a Case of Optic Nerve Head Drusen...
Current Minimal Invasive Angle Procedures Without Implants for the Treatment of Glaucoma...
Intra Ocular Lens Power Calculation and Optic Biometry...
Automated Perimetry
Carbonic Anhydrase Inhibitors
Visual Field Defect and Retinal Nerve Fiber Layer Defect in a Case of Optic Nerve Head Drusen...
Glokom-Katarakt 2023 , Vol 18 , Num 3
Abstract Free Full Text Similar Articles Mail to Author
Complication Management in Adenoviral Keratoconjunctivitis: Review
Emine Esra Karaca1, Zarife Nurbanu Aynaci1, Ozlem Evren Kemer1
University of Health Sciences, Ankara Bilkent City Hospital, Department of Ophthalmology, Ankara, Türkiye DOI : 10.37844/glau.cat.2023.18.14 Adenoviral epidemic keratoconjunctivitis (EKC) is characterized by a significant inflammation of the conjunctiva and cornea, resulting in the potential formation of corneal opacities and impaired vision. These symptoms can endure for an extended period, lasting several months. Epidemic keratoconjunctivitis represents the most severe manifestation, as it affects the cornea and results in the formation of subepithelial infiltrates. As of now, there is no approved treatment specifically for adenoviral eye infections, so the current approach focuses on providing relief from symptoms. However complications such as subepithelial infiltrates and membranes could be relieved by careful treatment and follow-up. This review describes current management strategies for engaging the complications of adenoviral keratoconjunctivitis. Keywords : Adenoviral keratoconjunctivitis, Subepithelial infiltrates, Tacrolimus
Home
Aims and Scope
Editorial Board
Instructions for Authors
Table of Contents
Contact